BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 15944648)

  • 1. Effects of 5-HT1B/1D receptor agonist rizatriptan on cerebral blood flow and blood volume in normal circulation.
    Okazawa H; Tsuchida T; Pagani M; Mori T; Kobayashi M; Tanaka F; Yonekura Y
    J Cereb Blood Flow Metab; 2006 Jan; 26(1):92-8. PubMed ID: 15944648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the 5-HT1B/1D agonist rizatriptan: update on recent research and implications for the future.
    Mannix LK
    Expert Opin Pharmacother; 2008 Apr; 9(6):1001-11. PubMed ID: 18377342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect.
    Edvinsson L; Uddman E; Wackenfors A; Davenport A; Longmore J; Malmsjö M
    Clin Sci (Lond); 2005 Sep; 109(3):335-42. PubMed ID: 15853772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative comparison of the bolus and steady-state methods for measurement of cerebral perfusion and oxygen metabolism: positron emission tomography study using 15O-gas and water.
    Okazawa H; Yamauchi H; Sugimoto K; Takahashi M; Toyoda H; Kishibe Y; Shio H
    J Cereb Blood Flow Metab; 2001 Jul; 21(7):793-803. PubMed ID: 11435791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rizatriptan does not change cerebral blood flow velocity during migraine attacks.
    Gori S; Morelli N; Bellini G; Bonanni E; Manca L; Orlandi G; Iudice A; Murri L
    Brain Res Bull; 2005 Apr; 65(4):297-300. PubMed ID: 15811594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERK1/2 inhibition attenuates cerebral blood flow reduction and abolishes ET(B) and 5-HT(1B) receptor upregulation after subarachnoid hemorrhage in rat.
    Beg SA; Hansen-Schwartz JA; Vikman PJ; Xu CB; Edvinsson LI
    J Cereb Blood Flow Metab; 2006 Jun; 26(6):846-56. PubMed ID: 16251886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral blood flow measurements by magnetic resonance imaging bolus tracking: comparison with [(15)O]H2O positron emission tomography in humans.
    Ostergaard L; Johannsen P; Høst-Poulsen P; Vestergaard-Poulsen P; Asboe H; Gee AD; Hansen SB; Cold GE; Gjedde A; Gyldensted C
    J Cereb Blood Flow Metab; 1998 Sep; 18(9):935-40. PubMed ID: 9740096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in cerebral blood flow and cerebral oxygen metabolism during neural activation measured by positron emission tomography: comparison with blood oxygenation level-dependent contrast measured by functional magnetic resonance imaging.
    Ito H; Ibaraki M; Kanno I; Fukuda H; Miura S
    J Cereb Blood Flow Metab; 2005 Mar; 25(3):371-7. PubMed ID: 15660103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attempts to improve absolute quantification of cerebral blood flow in dynamic susceptibility contrast magnetic resonance imaging: a simplified T1-weighted steady-state cerebral blood volume approach.
    Wirestam R; Knutsson L; Risberg J; Börjesson S; Larsson EM; Gustafson L; Passant U; Ståhlberg F
    Acta Radiol; 2007 Jun; 48(5):550-6. PubMed ID: 17520432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do 5HT1B/1D receptor agonists have an effect on mood and anxiety disorders?
    Morelli N; Gori S; Choub A; Maluccio MR; Orlandi G; Guazzelli M; Murri L
    Cephalalgia; 2007 May; 27(5):471-2. PubMed ID: 17448187
    [No Abstract]   [Full Text] [Related]  

  • 11. Separation of input function for rapid measurement of quantitative CMRO2 and CBF in a single PET scan with a dual tracer administration method.
    Kudomi N; Watabe H; Hayashi T; Iida H
    Phys Med Biol; 2007 Apr; 52(7):1893-908. PubMed ID: 17374918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reassessing the clinical efficacy of two MR quantitative DSC PWI CBF algorithms following cross-calibration with PET images.
    Chen JJ; Frayne R; Smith MR
    Phys Med Biol; 2005 Mar; 50(6):1251-63. PubMed ID: 15798320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pig brain stereotaxic standard space: mapping of cerebral blood flow normative values and effect of MPTP-lesioning.
    Andersen F; Watanabe H; Bjarkam C; Danielsen EH; Cumming P;
    Brain Res Bull; 2005 Jul; 66(1):17-29. PubMed ID: 15925140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential responses in CBF and CBV to cocaine as measured by fMRI: implications for pharmacological MRI signals derived oxygen metabolism assessment.
    Luo F; Schmidt KF; Fox GB; Ferris CF
    J Psychiatr Res; 2009 Aug; 43(12):1018-24. PubMed ID: 19135215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of a method using short inhalation of (15)O-O(2) for measuring cerebral oxygen extraction fraction with PET in healthy humans.
    Hattori N; Bergsneider M; Wu HM; Glenn TC; Vespa PM; Hovda DA; Phelps ME; Huang SC
    J Nucl Med; 2004 May; 45(5):765-70. PubMed ID: 15136624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the arterial fraction of human cerebral blood volume during hypercapnia and hypocapnia measured by positron emission tomography.
    Ito H; Ibaraki M; Kanno I; Fukuda H; Miura S
    J Cereb Blood Flow Metab; 2005 Jul; 25(7):852-7. PubMed ID: 15716851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging--comparison with positron emission tomography.
    Tanaka Y; Nariai T; Nagaoka T; Akimoto H; Ishiwata K; Ishii K; Matsushima Y; Ohno K
    J Cereb Blood Flow Metab; 2006 Feb; 26(2):291-300. PubMed ID: 16049427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the effects of adenosine receptor agonists on cerebral blood flow in uninjured and traumatically injured rat brain using continuous arterial spin-labeled magnetic resonance imaging.
    Kochanek PM; Hendrich KS; Jackson EK; Wisniewski SR; Melick JA; Shore PM; Janesko KL; Zacharia L; Ho C
    J Cereb Blood Flow Metab; 2005 Dec; 25(12):1596-612. PubMed ID: 15931163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans.
    Vyas KP; Halpin RA; Geer LA; Ellis JD; Liu L; Cheng H; Chavez-Eng C; Matuszewski BK; Varga SL; Guiblin AR; Rogers JD
    Drug Metab Dispos; 2000 Jan; 28(1):89-95. PubMed ID: 10611145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid measurement of cerebral blood flow with positron emission tomography.
    Iida H; Kanno I; Miura S
    Ciba Found Symp; 1991; 163():23-37; discussion 37-42. PubMed ID: 1815893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.